Efficacy of IVIG plus Rituximab Desensitization Therapy on HLA Antibodies is Independent of HLA Loci.

被引：0
|
作者：
Zhang, X. [1 ]
Jordan, S. [2 ]
机构：
[1] Cedars Sinai Hlth Syst, Comprehens Transplant Ctr, HLA & Immunogenet Lab, Los Angeles, CA USA
[2] Cedars Sinai Med Ctr, Comprehens Transplant Ctr, Los Angeles, CA 90048 USA
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2018年 / 18卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
A146
引用
收藏
页码：524 / 525
页数：2
相关论文
共 50 条
  • [41] Measurement of HLA antibody specificity (AB SP) by single antigen beads and MESF quantitation demonstrates efficacy of rituximab desensitization
    Pescovitz, MD
    Book, BK
    Rahman, A
    Vieira, CA
    Susskind, BM
    AMERICAN JOURNAL OF TRANSPLANTATION, 2005, 5 : 324 - 324
  • [42] SUCCESSFUL RENAL TRANSPLANTATION WITH POSITIVE CROSSMATCHES AND DONOR SPECIFIC HLA ANTIBODIES FOLLOWING HIGH DOSE IVIG THERAPY
    Zhang, Qiuheng
    Rajalingam, Raja
    McGuire, Suzanne
    Reed, Elaine F.
    Lipshutz, Gerald
    HUMAN IMMUNOLOGY, 2012, 73 : 83 - 83
  • [43] HLA Mismatching Has No Significant Impact on Kidney Transplant Outcomes of Highly-HLA Sensitized Patients Desensitized with IVIG ± Rituximab.
    Cao, Kai
    Vo, Ashley A.
    Lai, Chih-Hung
    Wang, Qi
    Ong, Geraldine
    Mehrnoush, Naim
    Jordan, Stanley C.
    Reinsmoen, Nancy L.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2009, 9 : 561 - 561
  • [44] DESENSITIZATION WITH IVIG AND RITUXIMAB, COMBINED WITH ALEMTUZUMAB INDUCTION, DOES NOT INCREASE RISK FOR VIRAL INFECTIONS IN HLA-SENSITIZED PEDIATRIC RENAL TRANSPLANT RECIPIENTS.
    Puliyanda, D.
    Kim, I.
    Petroysan, A.
    Galera, O.
    Pizzo, H.
    Kamil, E.
    Jordan, S.
    PEDIATRIC TRANSPLANTATION, 2017, 21 : 6 - 7
  • [45] Effect of Desensitization on Complement Activation by HLA-Specific Antibodies.
    Zachary, Andrea A.
    Lucas, Donna P.
    Montgomery, Robert A.
    Leffell, Mary S.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2009, 9 : 242 - 242
  • [46] Long-Term Assessment of the Safety and Efficacy of IVIG and Rituximab-Based Desensitization (DES)
    Choi, J.
    Kahwaji, J.
    Vo, A.
    Louie, S.
    Kang, A.
    Peng, A.
    Villicana, R.
    Puliyanda, D.
    Kim, I.
    Jordan, S.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2016, 16 : 316 - 316
  • [47] HLA antibody profiling in thoracic transplantation undergoing desensitization therapy
    Zeevi, Adriana
    Lunz, John
    CURRENT OPINION IN ORGAN TRANSPLANTATION, 2012, 17 (04) : 416 - 422
  • [48] Therapeutic preparations of IVIg contain naturally occurring anti-HLA-E antibodies that react with HLA-Ia (HLA-A/-B/-Cw) alleles
    Ravindranath, Mepur H.
    Terasaki, Paul I.
    Tho Pham
    Jucaud, Vadim
    Kawakita, Satoru
    BLOOD, 2013, 121 (11) : 2013 - 2028
  • [49] Course of Donor Specific Anti-HLA Antibodies After Induction Therapy with Rituximab in Renal Transplantation
    Baas, M.
    Allebes, W.
    van den Hoogen, M.
    Joosten, I.
    Hilbrands, L.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2017, 17 : 569 - 569
  • [50] Increased disease relapse in HLA-DPB1 matched recipients of unrelated donor transplants is not confined to pairs matched for the other five HLA loci.
    Shaw, BE
    Marsh, SGE
    Mayor, NP
    Madrigal, JA
    BLOOD, 2004, 104 (11) : 236A - 237A
12345